Neurochemical and neuroendocrine correlates of overactive bladder at first demyelinating episode.

about

Neurochemical and neuroendocrine correlates of overactive bladder at first demyelinating episode.

Item

http://www.wikidata.org/entity/Q48077052

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Neurochemical and neuroendocri ...... t first demyelinating episode.

@en

Neurochemical and neuroendocri ...... t first demyelinating episode.

@nl

type

Item

label

Neurochemical and neuroendocri ...... t first demyelinating episode.

@en

Neurochemical and neuroendocri ...... t first demyelinating episode.

@nl

prefLabel

Neurochemical and neuroendocri ...... t first demyelinating episode.

@en

Neurochemical and neuroendocri ...... t first demyelinating episode.

@nl

P1476

Neurochemical and neuroendocri ...... t first demyelinating episode.

@en

P2093

Constantinos Sfagos

http://www.w3.org/2001/XMLSchema#string

Georgios Koutsis

http://www.w3.org/2001/XMLSchema#string

Maria-Eleftheria Evangelopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

The neural control of micturition

Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies

Corticotropin releasing factor: a mediator of emotional influences on bladder function.

Duloxetine compared with placebo for treating women with symptoms of overactive bladder.

Treatment of the overactive bladder: possible central nervous system drug targets.

Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.

Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.

P304

955-958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NAU.22834

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manolis Markianos

P577

2015-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280583306

http://www.w3.org/2001/XMLSchema#string

P698

26227286

http://www.w3.org/2001/XMLSchema#string